Compare LUNG & XPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUNG | XPL |
|---|---|---|
| Founded | 1995 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 68.9M |
| IPO Year | 2020 | 2000 |
| Metric | LUNG | XPL |
|---|---|---|
| Price | $1.23 | $0.76 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $5.38 | $1.20 |
| AVG Volume (30 Days) | ★ 557.6K | 114.5K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.64 | ★ 42.86 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $90,497,000.00 | N/A |
| Revenue This Year | $2.48 | N/A |
| Revenue Next Year | $18.46 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $1.13 | $0.54 |
| 52 Week High | $3.86 | $0.98 |
| Indicator | LUNG | XPL |
|---|---|---|
| Relative Strength Index (RSI) | 38.47 | 47.46 |
| Support Level | $1.20 | $0.69 |
| Resistance Level | $1.65 | $0.79 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 5.06 | 53.71 |
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Solitario Resources Corp is an exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. Its core mineral property assets are: the Florida Canyon zinc project in Peru, the Lik zinc project in Alaska, and the Golden Crest project in South Dakota. Additionally, Solitario holds an interest in the Chambara project in Peru and also has two early-stage projects, the Cat Creek project and the Bright Angel project in Colorado. The company is conducting mineral exploration on its Golden Crest project, the Cat Creek project, and the Bright Angel project on its own.